3:32 PM
 | 
Dec 04, 2018
 |  BC Extra  |  Politics & Policy

In a first, FDA recognizes genetic database, removing regulatory hurdle

FDA formally recognized for the first time a public genetic database as a valid source of information to support clinical validity in premarket submissions for genetic tests, which could save developers the resources required to collect...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >